Dr. Matthew Hewitt has held roles in research and development over the past 10 years in both academia and industry. Over that time he has built and run successful programs in pre-clinical, IND-enabling, and clinical support settings using his extensive immunology and molecular biology experience.
Dr. Hewitt is currently Director of the Tumor Immunology & Microenvironment group at Bellicum Pharmaceuticals. His group focuses on understanding the underlying immunology of the tumour microenvironment and examines avenues to overcome it to increase CAR-T efficacy in solid tumours.
There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October